REFERENCES
- Anello, G., Gueant, R. M., Guéant, J. L., (2004). Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport, 15, 859–861. [PMID: 15073531].
- Bertram, L., & Tanzi, R. E. (2004). The current status of Alzheimer's disease genetics: What do we tell the patients? Pharmacology Research, 50(4), 385–396. [PMID: 15304236].
- Bi, S., Pang, S. H., Zhang, Y., &Wu, J. (2004). Effects of folate, Vit B12 and plasma homocysteine levels in Alzheimer's disease. Chinese Journal of Rehabilitation Medicine, 19, 40–42.
- Bi, X. H., Zhao, H. L., Zhang, Z. X., (2009). Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease. Neurobiology of Aging, 30, 1601–1607. [PMID: 18258338].
- Bosco, P., Guéant, R. M., Anello, G., (2004). Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 75, 1036–1038. [PMID: 15201366].
- Brunelli, T., Bagnoli, S., Giusti, B., (2001). The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease. Neuroscience Letters, 315, 103–105. [PMID: 21212568].
- Cochran, W. G. (1954). Some methods of strengthening the common X2 tests. Biometrics, 10, 417–451. [PMID: 16522921].
- Devlin, A. M., Clarke, R., Birks, J., (2006). Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population. American Journal of Clinical Nutrition, 83, 708–713. [PMID: 16522921].
- Dorszewska, J., Florczak, J., Rozycka, A., (2007). Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer's and Parkinson's diseases. Acta Neurobiologiae Experimentalis (Wars), 67, 113–129. [PMID: 17691219].
- Egger, M., Smith, G. D., Schneider, M., (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629–634. [PMID: 9310563].
- Elkins, J. S., Johnston, S. C., Ziv, E., (2007). Methylenetetrahydrofolate reductase C677T polymorphism and cognitive function in older women. American Journal of Epidemiology, 166, 672–678. [PMID: 17638709].
- Frosst, P., Blom, H. J., Milos, R., (1995). A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10, 111–113. [PMID: 7647779].
- Gatz, M., Reynolds, C. A., Fratiglioni, L., (2006). Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry, 63(2), 168–174. [PMID: 16461860].
- Giedraitis, V., Kilander, L., Degerman-Gunnarsson, M., (2009). Genetic analysis of Alzheimer's disease in the Uppsala longitudinal study of adult men. Dementia and Geriatric Cognitive Disorders, 27, 59–68. [PMID: 19141999].
- Hardy, J. (2006). A hundred years of Alzheimer's disease research. Neuron, 52, 3–13.
- Harold, D., Abraham, R., Hollingworth, P., (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics, 41(10), 1088–1093. [PMID: 19734902].
- Higgins, J. P., Thompson, S. G., Deeks, J. J., (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557–560. [PMID: 12958120].
- Huang, S. K., Chen, S. Q., Wang, Y. P., (2006). The correlations between the polymorphism of cystathionine synthas gene (CBS 844 ins 68) and meylene tetrahydrofolate reductase (MTHFR C677T) and Alzheimer's disease. Chinese Journal of Neuromedicine, 5(5), 468–470.
- Jiang, K. D., Li, F., Zhang, M. Y., (2004). A study on relationship between the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and Alzheimer's disease. Shanghai Archives of Psychiatry, 16(4), 196– 198.
- Jonathan, A. P., Lars, F., Sarah, L. S., (2001). Lack of replication of association findings in complex disease: An analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. European Journal of Human Genetics, 9, 437–444. [PMID: 11436125].
- Kang, S. S., Zhou, J., Wong, P. W., (1988). Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase. American Journal of Human Genetics, 43(4), 414–421. [PMID: 3177384].
- Keikhaee, M. R., Hashemi, S. B., Najmaabadi, H., & Noroozian, M. (2006). C677T methylentetrahydrofulate reductase and angiotensin converting enzyme gene polymorphisms in patients with Alzheimer's disease in Iranian population. Neurochemical Research, 31, 1079–1083. [PMID: 16906459].
- Kim, J. M., Stewart, R., Kim, S.W., (2008). Methylenetetrahydrofolate reductase gene and risk of Alzheimer's disease in Koreans. International Journal of Geriatric Psychiatry, 23, 454–459. [PMID: 17932993].
- Klerk, M., Verhoef, P., Clarke, R., (2002). MTHFR 677C-T polymorphism and risk of coronary heart disease—A meta-analysis. Journal of the American Medical Association, 288, 2023–2031. [PMID: 12387655].
- Lambert, J. C., Heath, S., Even, G., (2009). European Alzheimer's Disease Initiative Investigators. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics, 41(10), 1094–1099. [PMID: 19734903].
- Langevin, S. M., Lin, D., Matsuo, K., (2009). Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicology Letters, 184, 73–80. [PMID: 18840514].
- Li, K. S., Liu, S. Y., Yao, S. P., (2009). Interaction between interleukin-8 and methylenetetrahydrofolate reductase genes modulates Alzheimer's disease risk. Dementia and Geriatric Cognitive Disorders, 27, 286–291. [PMID: 19246914].
- Linnebank. (2004). Lack of genetic dispositions to hyperhomocysteinemiain Alzheimer disease. American Journal of Medical Genetics, 131A, 101–102. [PMID: 15389705].
- Ma, J., Stampfer, M. J., Hennekens. C. H., (1994). Methelenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine and risk of myocardial infarction in US physicians. Circulation, 2410–2416. [PMID: 8921781].
- Martinez, M. E., Thompson, P., Jacobs, E. T., (2006). Dietary factors and biomarkers involved in the methyenetetrahydrofolate reductase genotype-colrectal adenoma pathway. Gastroenterology, 131, 1706–1716. [PMID: 17087956].
- McKhann, G., Drachman, D., Folstein, M., (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34(7), 939–944. [PMID: 6610841].
- Nishiyama, M., Kato, Y., Hashimoto, M., (1999). Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia—An epidemiological study using the polymerase chain reaction (PCR) method. Journal of Epidemiologv, 10, 163–172. [PMID: 10860300].
- Pollak, R. D., Pollak, A., Idelson, M., (2000). The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia. Journal of the American Geriatrics Society, 48(6), 664–668.
- Postiglione, A., Milan, G., Ruocco, A., (2001). Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia: A case-control study. Gerontology, 47, 324–329. [PMID: 11721146].
- Qian, X. Q., Lu, Z. G., Tan, M., (2007). Meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. European Journal of Human Genetics, 15, 1239–1245. [PMID: 17726486].
- Regland, B., Blennow, K., Germgerd, T., (1999). The role of the polymorphic genes apolipoprotein E and methylene-tetrahydrofolate reductase in the development of dementia of the Alzheimer type. Dementia and Geriatric Cognitive Disorders, 10, 245–251. [PMID: 10364640].
- Religa, D., Styczynska, M., Peplonsk, B., (2003). Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 16, 64–70. [PMID: 12784029].
- Seripa, D., Forno, G. D., Matera, M. G., (2003). Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients. Neurobiology of Aging, 24(7), 933–939. [PMID: 12928053].
- Stephen, P. M., Kevin, B. D., John, T. L., (2002). Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke, 33, 2351–2356. [PMID: 12364720].
- Styczynska, M., Strosznajder, J. B., Religa, D., (2008). Association between genetic and environmental factors and the risk of Alzheimer's disease. Folia Neuropathologica, 46, 249–254. [PMID: 19169966].
- Wakutani, Y., Kowa, H., Kusumi, M., (2002). Genetic analysis of vascular factors in Alzheimer's disease. Annals of the New York Academy of Sciences, 977, 232–238. [PMID: 12480755].
- Wang, B. B., Jin, F., Kan, R., (2005). Association of MTHFR gene polymorphism C677T with susceptibility to late-onset Alzheimer's disease. Journal of Molecular Neuroscience, 27, 23–28. [PMID: 16055944].
- Wehr, H., Bednarska-Makaruk, M., Lojkowska, W., (2006). Differences in risk factors for dementia with neurodegenerativetraits and for vascular dementia. Dementia and Geriatric Cognitive Disorders, 22, 1–7. [PMID: 16645274].
- Winchester, D. E., Wen, X., Xie, L., & Bavry, A. A. (2010). Evidence of pre-procedural statin therapy a meta-analysis of randomized trials. Journal of the American College of Cardiology, 56(14), 1099–1109. [PMID: 20825761].
- Xin, X. Y., Song, Y. Y., Ma, J. F., (2009). Gene polymorphisms and risk of adult early-onset ischemic stroke: A meta-analysis. Thrombosis Research, 124, 619–124. [PMID: 19660787].
- Yuan, Y. G., Ye, Q., Chen, Y., (2007). The correlations between the polymorphism of meylene tetrahydrofolate reductase (MTHFR C677T) gene and Alzheimer's disease. Chinese Journal of Geriatric, 26(10), 767–769.
- Zhang, J. P., Dai, Q. D., Lu, W. G., (2008). The association between the polymorphism of meylene tetrahydrofolate reductase (MTHFR C677T) gene and Alzheimer's disease. Chinese Journal of Postgraduates of Medicine, 31, 40–42.
- Zhang, Y. D., Ke, X. Y., Wei, S., (2005). Relationship of homocysteine and gene polymorphisms of its related metabolic enzymes with Alzheimer's disease. Chinese Medical Science Journal, 20(4), 247–251. [PMID: 16422253].
- Zintzaras, E., Uhlig, K., Koukoulis, G. N., (2007). Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: A meta-analysis. Journal of Human Genetics, 52, 881–890. [PMID: 17805475].
- Zuliani, G., Ble, A., Zanca, R., (2001). Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurologica Scandinavica, 103, 304–308. [PMID: 18597785].